内视镜狭窄管理设备市场- 产品（支架、球囊扩张器、球囊充气装置、探条扩张器）、应用（食道、结肠、胆道）、最终用户（医院、门诊手术中心） - 全球预测（ 2024 - 2032）

内视镜狭窄管理设备市场规模预计在2024 年至2032 年间将以5.8% 的复合年增长率增长。治疗解决方案。根据美国国家医学图书馆的资料，到2030 年，欧洲和美国将有超过700 万人患有发炎性肠道疾病(IBD)。和安全性，从而提高采用率。

对胃肠道疾病的日益认识和早期诊断也刺激了对这些设备的需求。全球人口老化更容易出现此类疾病，这也增加了产品的部署。这些设备提供的微创手术可以减少恢復时间并改善患者的治疗效果，这也使它们成为首选。有利的监管批准、不断增加的医疗保健支出和报销政策进一步推动了市场的成长。

整个市场分为产品、应用、最终用户和地区。

从产品来看，球囊扩张器领域的内视镜狭窄管理设备市场将在 2024 年至 2032 年间以显着速度成长，因为它们能够有效地以微创方式治疗狭窄。这些设备可以精确扩张胃肠道狭窄区域，同时减少手术需求并促进患者復原。快速进步正在提高其安全性和有效性。胃肠道疾病的盛行率不断上升，以及医疗保健专业人员对先进治疗方案的认识不断提高，正在推动产品需求。

由于克隆氏症和大肠直肠癌等大肠直肠疾病发生率的上升，预计到 2032 年，结肠应用领域的内视镜狭窄管理设备产业将以显着速度成长。日益提高的认识和早期诊断正在推动对有效治疗方案的需求。内视镜设备的技术发展正在提高精度和患者治疗效果。对微创手术的日益青睐和人口老化的不断增长将进一步推动该细分市场的成长。

从地区来看，由于胃肠道疾病盛行率上升、医疗保健支出增加以及先进医疗技术的普及，亚太地区内视镜狭窄管理设备市场将在 2024 年至 2032 年间呈现强劲成长。对胃肠道疾病的认识不断提高以及早期诊断正在推动该地区对这些设备的需求。人口老化和微创手术的日益普及也将推动区域产业的进步。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 内视镜狭窄治疗设备的持续技术进步
    • 导致狭窄的疾病/病症盛行率不断增加
    • 提高对狭窄早期诊断的认识
    • 使用内视镜进行微创手术的增加
  • 产业陷阱与挑战
    • 设备审批的严格监管要求
    • 使用球囊扩张和支架的内视镜手术成本高昂
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 支架
  • 金属支架
  • 塑胶支架
  • 可生物降解支架
• 球囊扩张器
  • 球囊扩张器导管
  • 气球充气装置
• 探条扩张器
• 其他产品

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 食道
• 结肠
• 幽门
• 胆道
• 其他应用

第 7 章：市场估计与预测：按最终用户划分，2021 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Cook Medical Inc.
• Becton, Dickinson and Company
• Merit Medical Systems
• Medi-Globe GmbH
• PanMed Us
• HOBBS MEDICAL, INC.
• Micro-Tech (Nanjing) Co., Ltd
• Steris plc (Diagmed Healthcare)
• Taewoong Medical Co., Ltd.

Endoscopic Stricture Management Device Market size is projected to grow at 5.8% CAGR between 2024 and 2032. The rising prevalence of gastrointestinal disorders, such as Crohn's disease and esophageal strictures, is necessitating several effective treatment solutions. According to data from the National Library of Medicine, more than 7 million people in Europe and the U.S. will be suffering from inflammatory bowel diseases (IBD) by 2030. Significant advancements in endoscopy are enhancing the precision, efficacy, and safety of stricture management, leading to increasing adoption rates.

The growing awareness and early diagnosis of gastrointestinal conditions is also spurring the demand for these devices. The aging global population, which is more prone to such disorders is also increasing the product deployment. Minimally invasive procedures offered by these devices to reduce recovery times and improve patient outcomes is also making them a preferred choice. The favorable regulatory approvals, increasing healthcare expenditure, and reimbursement policies are further driving the market growth.

The overall market is segregated into product, application, end-user, and region.

Based on product, the endoscopic stricture management device market from the balloon dilators segment will grow at notable pace between 2024 and 2032, on account of their effectiveness in treating strictures with minimal invasiveness. These devices offer precise dilation of narrowed areas in the gastrointestinal tract while reducing the need for surgery and enhancing patient recovery. Rapid advancements are improving their safety and efficacy. The increasing prevalence of gastrointestinal disorders and the rising awareness among healthcare professionals about advanced treatment options are fueling the product demand.

Endoscopic stricture management device industry from the colonic application segment is estimated to grow at significant rate up to 2032, led by the rising incidence of colorectal diseases, such as Crohn's disease and colorectal cancer. The increasing awareness and early diagnosis are driving the demand for effective treatment options. Technological developments in endoscopic devices are improving precision and patient outcomes. The rising preference for minimally invasive procedures and the growing aging population will further boost the segment growth.

Regionally, the Asia Pacific endoscopic stricture management device market will showcase strong gains between 2024 and 2032, driven by the rising prevalence of gastrointestinal disorders, increasing healthcare expenditure, and expanding access to advanced medical technologies. The growing awareness and early diagnosis of gastrointestinal conditions is boosting the demand for these devices in the region. The aging population and the increasing adoption of minimally invasive procedures will also push the regional industry progression.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Ongoing technological advances in endoscopic stricture management devices
    • 3.2.1.2 Increasing prevalence of diseases/disorders leading to strictures
    • 3.2.1.3 Increasing awareness towards early diagnosis of strictures
    • 3.2.1.4 Increase in minimally invasive surgical procedures using endoscopes
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory requirements for device approval
    • 3.2.2.2 High cost of endoscopic surgical procedures using balloon dilation and stents
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Million)

• 5.1 Key trends
• 5.2 Stents
  • 5.2.1 Metal stents
  • 5.2.2 Plastic stents
  • 5.2.3 Biodegradable stents
• 5.3 Balloon dilators
  • 5.3.1 Balloon dilator catheters
  • 5.3.2 Balloon inflation devices
• 5.4 Bougie dilators
• 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)

• 6.1 Key trends
• 6.2 Esophageal
• 6.3 Colonic
• 6.4 Pyloric
• 6.5 Biliary
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End User, 2021 - 2032 ($ Million)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgery centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Boston Scientific Corporation
• 9.2 Olympus Corporation
• 9.3 CONMED Corporation
• 9.4 Cook Medical Inc.
• 9.5 Becton, Dickinson and Company
• 9.6 Merit Medical Systems
• 9.7 Medi-Globe GmbH
• 9.8 PanMed Us
• 9.9 HOBBS MEDICAL, INC.
• 9.10 Micro-Tech (Nanjing) Co., Ltd
• 9.11 Steris plc (Diagmed Healthcare)
• 9.12 Taewoong Medical Co., Ltd.